End-of-day quote
Other stock markets
|
||
- AUD | - |
04-03 | Opthea Limited Announces Board Changes | CI |
02-29 | Opthea Posts H1 FY24 Loss per Share of $0.1623; R&D Expenses Jump | MT |
Chart calendar Circadian Technologies Limited
Upcoming events on Circadian Technologies Limited
Past events on Circadian Technologies Limited
11/05/2024 15:18 | Retina World Congress - David Eichenbaum |
10/05/2024 21:02 | Retina World Congress - Jordana G. Fein |
09/05/2024 13:35 | Retina World Congress - Panel |
04/05/2024 16:35 | Association for Research in Vision and Ophthalmology Meeting |
11/04/2024 20:45 | Needham Healthcare Conference |
03/04/2024 15:00 | Investor Meeting - Key Opinion Leader |
10/03/2024 | Leerink Partners Global Biopharma Conference |
28/02/2024 22:07 | Q2 2024 Earnings Release |
02/12/2023 10:06 | FLORetina Congress |
29/11/2023 22:00 | Annual General Meeting |
15/11/2023 12:30 | Jefferies London Healthcare Conference - Fireside Chat |
02/11/2023 20:36 | American Academy Of Ophthalmology Meeting |
13/09/2023 17:00 | H.C. Wainwright Global Investment Conference |
30/08/2023 23:19 | Q4 2023 Earnings Release |
27/08/2023 | Rights Issue: 100 new shares @ 0.46 AUD for 307 existing shares |
01/08/2023 16:00 | American Society of Retina Specialists Conference |
01/08/2023 00:10 | American Society of Retina Meeting |
27/07/2023 16:35 | Opthalmology Innovation Summit |
07/06/2023 19:00 | Jefferies Global Healthcare Conference |
18/05/2023 22:00 | Analyst Meeting - EF Hutton |
Annual results
Fiscal Period | June | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,91 0,00 - | 0,81 0,00 - | 0,09 56,7 -99.83% | 0,29 0,71 -59.59% | 0,59 0,50 18% | 0,92 |
EBITDA Million AUD | Released Forecast Spread | -35,5 -29,7 -19.76% | -24,9 -37,4 33.45% | -68,8 -57,1 -20.37% | -140 -109 -27.77% | -231 -177 -30.41% | -264 |
EBIT Million AUD | Released Forecast Spread | -35,5 -29,7 -19.67% | -25,1 -37,5 33.24% | -68,9 -64,2 -7.44% | -140 -112 -25.41% | -231 -199 -16.32% | -277 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -35,5 -21,5 -65.34% | -25,1 -40,1 37.5% | -68,9 -82,9 16.87% | -144 -117 -22.37% | -229 -211 -8.58% | -292 |
Net income Million AUD | Released Forecast Spread | -20,9 -21,8 4.08% | -16,5 -33,3 50.42% | -62,2 -65,5 5.14% | -135 -114 -18.39% | -219 -208 -5.35% | -278 |
EPS AUD | Released Forecast Spread | -0,14 -0,09 -52.82% | -0,10 -0,13 21.96% | -0,19 -0,22 12.65% | -0,38 -0,34 -14.21% | -0,50 -0,45 -10.79% | -0,46 |
Announcement Date | 08/08/19 | 27/08/20 | 29/08/21 | 29/08/22 | 30/08/23 | - |
Quarterly results
Fiscal Period | June | 2020 S1 | 2020 S2 | 2021 S1 | 2021 S2 | 2022 S1 | 2022 S2 | 2023 S1 | 2023 S2 | 2024 S1 | 2024 S2 |
---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million AUD | Released Forecast Spread | 0,27 0,00 - | 0,54 0,00 - | 0,31 0,58 -45.34% | -0,19 56,6 -100.34% | -0,07 0,42 -115.88% | 1,91 0,36 426.18% | 0,29 0,49 -41.09% | 3,08 0,04 8010.58% | 0,15 | |
EBITDA Million AUD | Released Forecast Spread | -11,5 -15,5 25.75% | -13,4 -32,7 58.99% | -18,4 -14,9 -23.71% | -142 -108 -31.2% | ||||||
EBIT Million AUD | Released Forecast Spread | -11,6 -15,5 25.3% | -13,5 -32,8 58.89% | -38,5 -19,1 -101.99% | -16,1 -41,4 60.95% | -56,2 -45,0 -24.86% | -83,0 -56,5 -46.92% | -114 -61,3 -86.06% | -104 -90,1 -15.74% | -142 | -163 |
Earnings before Tax (EBT) Million AUD | Released Forecast Spread | -11,5 -15,0 23.57% | -13,6 -32,5 58.16% | -38,5 -18,9 -103.6% | -16,1 -41,4 60.95% | -84,8 -62,8 -34.89% | -116 -69,7 -66.63% | -107 -108 1.25% | -151 | ||
Net income Million AUD | Released Forecast Spread | -7,62 -15,0 49.2% | -8,91 -32,5 72.59% | -35,0 -16,4 -113.14% | -10,3 -34,9 70.41% | -79,9 -61,4 -30.1% | -113 -63,1 -79.22% | -101 -102 1.15% | -148 -122 -21.52% | -153 | |
EPS AUD | Released Forecast Spread | -0,12 -0,06 -95.83% | -0,02 -0,10 76% | -0,15 -0,10 -48.67% | -0,23 -0,20 -15.8% | -0,24 -0,18 -33.8% | -0,24 -0,22 -9.98% | -0,25 -0,19 -32.99% | -0,22 | ||
Announcement Date | 25/02/20 | 27/08/20 | 21/02/21 | 29/08/21 | 27/02/22 | 29/08/22 | 22/02/23 | 30/08/23 | 28/02/24 | - |
30/06/2024 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
15/07/2024 06:45 | ADDLIFE AB: Q2 2024 Earnings Release |
21/07/2024 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
23/07/2024 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
23/07/2024 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
23/07/2024 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
24/07/2024 | LONZA GROUP AG: Q2 2024 Earnings Release |
25/07/2024 06:00 | BACHEM HOLDING AG: Q2 2024 Earnings Release |
25/07/2024 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Circadian Technologies Limited
23/05/2024 12:00 | CUREVAC N.V.: Q1 2024 Earnings Release |
22/05/2024 06:00 | EVOTEC SE: Q1 2024 Earnings Release |
21/05/2024 22:14 | ALVOTECH: Q1 2024 Earnings Release |
21/05/2024 12:00 | EXSCIENTIA PLC: Q1 2024 Earnings Release |
17/05/2024 07:00 | BIOARCTIC AB: Q1 2024 Earnings Release |
15/05/2024 21:05 | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
15/05/2024 12:00 | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
14/05/2024 | GNI GROUP LTD.: Q1 2024 Earnings Release |
14/05/2024 21:05 | NUVATION BIO INC.: Q1 2024 Earnings Release |
14/05/2024 12:30 | ABSCI CORPORATION: Q1 2024 Earnings Release |
- Stock Market
- Equities
- OPT Stock
- Stock
- Calendar Circadian Technologies Limited